For the last 30 years, the production of affinity reagents and particularly antibodies for research and therapeutic applications has been dominated by hybridoma and polyclonal technologies ...

There is, of course, another advantage. “Recombinant in vitro production using antibody libraries and modern DNA technology, instead of laboratory animals and hybridoma cell lines, is ...

Antibodies bind to specific antigens on pathogens. This means that only one type of antibody will bind to a matching antigen. Scientists discovered that we could make antibodies to bind to ...

Antibodies bind to specific antigens on pathogens. This means that only one type of antibody will bind to a matching antigen. For example, an antibody that can recognise an antigen on the ...

This article explores how broadly neutralizing antibodies are being researched, not only for their potential in the ...

Recombinant ones are monoclonal, and here are the key steps involved in their production. Recombinant antibody production involves the use of recombinant DNA technology to produce an antibody.

Many vaccines work by introducing a protein to the body that resembles part of a virus. Ideally, the immune system will produce long-lasting antibodies recognizing that specific virus, thereby ...

Anti-idiotypic antibodies (anti-ID Ab) are antibodies that identify and attach to the idiotypic center of other antibodies. Anti-idiotype antibodies are commonly employed in therapeutic drug ...

Scientists discovered that repetitive HIV vaccinations can lead the body to produce antibodies targeting the immune complexes ...